Home › Funds › RTW INVESTMENTS, LP › IMCR
RTW INVESTMENTS, LP position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
RTW INVESTMENTS, LP reported holding 4,869,798 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$147.5M, representing 1.49% of its reported portfolio and ranking #22 among its reported holdings. RTW INVESTMENTS, LP has disclosed IMCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's IMCR position evolved
RTW INVESTMENTS, LP first disclosed a stake in IMCR in Q3 2023 at 6,096,387 shares (US$316.4M). The position peaked in Q4 2023 at 6,096,387 shares, worth US$416.5M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 4,869,798 shares valued at US$147.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.10M | $316.40M | New |
| Q4 2023 | 6.10M | $416.51M | Hold |
| Q1 2024 | 6.02M | $391.28M | Reduce |
| Q2 2024 | 4.87M | $165.04M | Reduce |
| Q3 2024 | 4.87M | $151.60M | Hold |
| Q4 2024 | 4.87M | $143.66M | Hold |
| Q1 2025 | 4.87M | $144.49M | Hold |
| Q2 2025 | 4.87M | $152.81M | Hold |
| Q3 2025 | 4.87M | $176.92M | Hold |
| Q4 2025 | 4.87M | $169.03M | Hold |
| Q1 2026 | 4.87M | $146.82M | Hold |
| Q2 2026 | 4.87M | $154.62M | Hold |
| Q3 2026 | 4.87M | $147.51M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 26 other funds we track also report a position in IMCR — the largest reported positions include Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M), Vestal Point Capital, LP (US$57.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- Bellevue Group AG 2.79M sh · $88.53M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.65M sh · $84.12M · Q2 2026
- Vestal Point Capital, LP 1.80M sh · $57.15M · Q2 2026
- Caligan Partners LP 1.38M sh · $43.86M · Q2 2026
- Kynam Capital Management, LP 1.38M sh · $41.65M · Q3 2026
- BVF INC/IL 1.29M sh · $41.10M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.14M sh · $34.41M · Q3 2026
- Trails Edge Capital Partners, LP 1.06M sh · $32.21M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 928.00K sh · $28.11M · Q3 2026
- Frazier Life Sciences Management, L.P. 484.78K sh · $15.39M · Q2 2026
- Logos Global Management LP 500.00K sh · $15.14M · Q3 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held IMCR?
RTW INVESTMENTS, LP has disclosed IMCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in IMCR?
As of Q3 2026, RTW INVESTMENTS, LP holds 4.87M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $147.51M, representing 1.49% of its reported portfolio and ranking #22.
Has RTW INVESTMENTS, LP been buying or selling IMCR?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in IMCR. The position peaked in Q4 2023 at 6.10M shares.
Which other funds hold IMCR?
Other major institutional holders of IMCR include Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, Vestal Point Capital, LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.